Dr. Riyaz Bashir, Director, Vascular and Endovascular Medicine at Temple Health explains the applications for Balloon Pulmonary Angioplasty, or BPA. BPA is a minimally invasive treatment for certain patients with Chronic Thromboembolic Pulmonary Hypertension (CTEPH), Chronic Thromboembolic Disease (CTED), and lingering Pulmonary Arterial Hypertension (PAH) after Pulmonary thromboendarterectomy (PTE) surgery. To date, Temple has conducted more than 257 BPAs.